Welcome to our dedicated page for China Sxt Pharmaceuticals SEC filings (Ticker: SXTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
China SXT Pharmaceuticals filings document foreign private issuer disclosures for a Nasdaq-listed specialty pharmaceutical company focused on Traditional Chinese Medicine Pieces and TCM Homologous Supplements. The company’s Form 6-K reports cover material events, securities purchase agreements, registered direct offerings, Class A ordinary shares, pre-funded warrants, and shelf registration references tied to its capital-raising activity.
The filings also record shareholder-meeting materials, proxy documentation, amendments to the memorandum and articles of association, and the creation of a dual-class share structure with Class A Ordinary Shares and Class B Ordinary Shares. These disclosures frame SXTC’s governance, voting rights, security structure, offering documents, and related legal opinions as a British Virgin Islands company reporting under Form 20-F status.